TechNet-21 - Forum

This forum provides a place for members to ask questions, share experiences, coordinate activities, and discuss recent developments in immunization.
  1. Alba Vilajeliu
  2. Programme management
  3. Thursday, 24 March 2022

Content: This slide set summarizes WHO latest recommendations and considerations for choosing COVID-19 vaccine products with WHO Emergency Use List (EUL) (currently available under COVAX).

Objective: To help orient the Ministry of Health (MoH) and National Immunization Advisory Committee Group (NITAG) in their COVID-19 vaccine product choices to optimize their portfolio.

The information contained in this slide set is current as of 18 March 2022. It has been developed based on WHO SAGE Interim guidance documents, technical documents, briefs, and webpages. This slide set will be periodically updated.

https://www.technet-21.org/en/library/main/7792-considerations-for-choosing-covid-19-vaccine-products 

References
  1. https://www.technet-21.org/en/library/main/7792-considerations-for-choosing-covid-19-vaccine-products


There are no replies made for this post yet.
Be one of the first to reply to this post!